Facebook Twitter LinkedIn Instagram Email Printer Google Plus

COVID-19

Considerations for the pricing of health insurance products amidst a global crisis.

Partner, Health & Life Sciences, Oliver Wyman
Senior Advisor, Health & Life Sciences, Oliver Wyman

Part 2: Healthcare’s ‘Corona Effect’

Ten expectations regarding voluntary offerings, telemedicine, direct contracting, and more as COVID-19 unfolds.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Times of turmoil caused by COVID-19 allow for the formation of deeper relationships with customers, members, and society.

Partner, Health & Life Sciences, Oliver Wyman
Global Head, Health Services, Oliver Wyman